Gary Sender, Chief Financial Officer

NBRV 206,352 shares

The estimated Net Worth of Gary Sender is at least $109,985.62. Gary Sender owns over 206,352 units of Nabriva Therapeutics Plc stock worth over $109,985.62.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
30th September 2020NBRV - Nabriva Therapeutics Plc312Payment by withholding206,352$0.53$166.30$109,985.62
21st August 2019NBRV - Nabriva Therapeutics Plc3,390Payment by withholding19,214$2.08$7,051.20$39,965.12
19th August 2019NBRV - Nabriva Therapeutics Plc11,250Exercise of derivative22,604$0.00
31st January 2020NBRV - Nabriva Therapeutics Plc4,295Payment by withholding78,669$1.35$5,798.25$106,203.15
6th February 2020NBRV - Nabriva Therapeutics Plc105,000Grant/award etc.183,669$0.00
28th February 2020NBRV - Nabriva Therapeutics Plc301Payment by withholding194,281$1.35$406.35$262,279.35
31st March 2020NBRV - Nabriva Therapeutics Plc301Payment by withholding193,980$0.58$173.08$111,538.50
30th April 2020NBRV - Nabriva Therapeutics Plc301Payment by withholding193,679$0.55$165.04$106,194.20
31st May 2020NBRV - Nabriva Therapeutics Plc312Payment by withholding199,554$1.14$355.68$227,491.56
30th June 2020NBRV - Nabriva Therapeutics Plc312Payment by withholding199,242$0.67$210.48$134,408.65
31st July 2020NBRV - Nabriva Therapeutics Plc312Payment by withholding198,930$0.76$237.12$151,186.80
20th August 2020NBRV - Nabriva Therapeutics Plc3,204Payment by withholding206,976$0.65$2,074.91$134,037.66
19th August 2020NBRV - Nabriva Therapeutics Plc11,250Exercise of derivative210,180$0.00
31st August 2020NBRV - Nabriva Therapeutics Plc312Payment by withholding206,664$0.62$193.25$128,007.68